Combinatorial targeting of a specific EMT/MET network by macroH2A variants safeguards mesenchymal identity

PLoS One. 2023 Jul 11;18(7):e0288005. doi: 10.1371/journal.pone.0288005. eCollection 2023.

Abstract

Generation of induced pluripotent stem cells from specialized cell types provides an excellent model to study how cells maintain their stability, and how they can change identity, especially in the context of disease. Previous studies have shown that chromatin safeguards cell identity by acting as a barrier to reprogramming. We investigated mechanisms by which the histone macroH2A variants inhibit reprogramming and discovered that they work as gate keepers of the mesenchymal cell state by blocking epithelial transition, a step required for reprogramming of mouse fibroblasts. More specifically, we found that individual macroH2A variants regulate the expression of defined sets of genes, whose overall function is to stabilize the mesenchymal gene expression program, thus resisting reprogramming. We identified a novel gene network (MSCN, mesenchymal network) composed of 63 macroH2A-regulated genes related to extracellular matrix, cell membrane, signaling and the transcriptional regulators Id2 and Snai2, all of which function as guardians of the mesenchymal phenotype. ChIP-seq and KD experiments revealed a macroH2A variant-specific combinatorial targeting of the genes reconstructing the MSCN, thus generating robustness in gene expression programs to resist cellular reprogramming.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Membrane
  • Cellular Reprogramming* / genetics
  • Chromatin Immunoprecipitation Sequencing
  • Chromatin* / genetics
  • Extracellular Matrix
  • Mice

Substances

  • Chromatin

Grants and funding

This work was supported by grants to DT from the Greek General Secretariat for Research and Innovation (GSRI) (Cooperative Grants Synergasia I #969, Excellence Award Aristeia I #1567), European Committee FP7 projects (STPredicta, and Biofos), from the European Economic Area (EL0084), and from the KMW offsets program. DV was supported by a scholarship from the Bodossaki Foundation and EK from the State Scholarships Foundation (Operational Programme MIS-5000432) and from the BIOIMAGING.GR (MIS-5002755). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.